2024
Botulinum Toxin Treatment of Psoriasis—A Comprehensive Review
Ghaseminejad-Bandpey A, Etemadmoghadam S, Jabbari B. Botulinum Toxin Treatment of Psoriasis—A Comprehensive Review. Toxins 2024, 16: 449. PMID: 39453225, PMCID: PMC11510791, DOI: 10.3390/toxins16100449.Peer-Reviewed Original ResearchConceptsOpen-label studyClinical trialsAnimal studiesPlacebo-controlled studyInjection of botulinum toxinPsoriatic skin lesionsLevels of interleukinsBotulinum toxin injectionOpen-labelDouble-blindBotulinum toxin treatmentCase reportInflammatory cellsPsoriatic plaquesSkin lesionsSmall dosesToxin injectionToxin treatmentLiterature searchBotulinum toxinRelevant articlesPsoriasisInterleukinHuman dataDose
2020
Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene modulation: A comprehensive review
Lee K, Ahn B, Cha D, Jang W, Choi E, Park S, Park J, Oh J, Jung D, Park H, Park J, Suh Y, Jin D, Lee S, Jang Y, Yoon T, Park M, Seong Y, Pyo J, Yang S, Kwon Y, Jung H, Lim C, Hong J, Park Y, Choi E, Shin J, Kronbichler A. Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene modulation: A comprehensive review. Autoimmunity Reviews 2020, 19: 102469. PMID: 31918027, DOI: 10.1016/j.autrev.2020.102469.Peer-Reviewed Original ResearchConceptsImmunopathogenesis of autoimmune diseasesSystemic lupus erythematosusAutoimmune diseasesShort interfering ribonucleic acidTumor necrosis factorInflammatory bowel diseaseCytotoxic T-lymphocyte-associated antigen 4T-lymphocyte-associated antigen 4Rheumatoid arthritisTreatment of autoimmune disordersMultiple sclerosisPathogenic inflammatory responsesMolecular basis of autoimmune diseasesMechanisms of autoimmune diseasesAnti-inflammatory cytokinesLevels of interleukinsInadequate immune activationCTLA-4Antigen 4Cytokine antagonistsInvestigate cytokine regulationInterferon-gLupus erythematosusAutoimmune disordersGene modules
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply